Technical Analysis for SPHS - Sophiris Bio, Inc.

Grade Last Price % Change Price Change
grade F 1.08 -3.57% -0.04
SPHS closed down 3.57 percent on Friday, March 22, 2019, on 1.9 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Flat Up
See historical SPHS trend table...

Date Alert Name Type % Chg
Mar 22 Fell Below 50 DMA Bearish 0.00%
Mar 22 20 DMA Support Bullish 0.00%
Mar 21 MACD Bullish Centerline Cross Bullish -3.57%
Mar 21 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.57%
Mar 21 Calm After Storm Range Contraction -3.57%
Mar 21 Doji - Bearish? Reversal -3.57%
Mar 21 Earnings Movers Other -3.57%
Mar 20 50 DMA Support Bullish -3.57%
Mar 20 Calm After Storm Range Contraction -3.57%
Mar 20 Earnings Movers Other -3.57%

Older signals for SPHS ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Sophiris Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the research, development, and commercialization of products for the treatment of urological diseases. Its primary product candidate includes PRX302, which has completed a Phase IIb clinical trial for treatment for the symptoms of benign prostatic hyperplasia, as well as for the treatment of prostate cancer. The company was formerly known as Protox Therapeutics Inc. and changed its name to Sophiris Bio, Inc. in April 2012. Sophiris Bio, Inc. is headquartered in La Jolla, California.
Medicine Biopharmaceutical Medical Specialties Prostate Cancer Urology Benign Prostatic Hyperplasia Treatment Of Prostate Cancer Astellas Pharma Histopathology Hyperplasia Treatment Of Urological Diseases Urological Diseases
Is SPHS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.05
52 Week Low 0.75
Average Volume 127,417
200-Day Moving Average 2.1315
50-Day Moving Average 1.0806
20-Day Moving Average 1.0433
10-Day Moving Average 1.0598
Average True Range 0.082
ADX 18.75
+DI 18.8991
-DI 22.4874
Chandelier Exit (Long, 3 ATRs ) 0.954
Chandelier Exit (Short, 3 ATRs ) 1.1204
Upper Bollinger Band 1.1848
Lower Bollinger Band 0.9018
Percent B (%b) 0.63
BandWidth 27.125467
MACD Line 0.0018
MACD Signal Line -0.0152
MACD Histogram 0.017
Fundamentals Value
Market Cap 32.52 Million
Num Shares 30.1 Million
EPS -0.24
Price-to-Earnings (P/E) Ratio -4.50
Price-to-Sales 0.00
Price-to-Book 4.97
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.28
Resistance 3 (R3) 1.28 1.21 1.24
Resistance 2 (R2) 1.21 1.16 1.21 1.23
Resistance 1 (R1) 1.15 1.13 1.12 1.15 1.22
Pivot Point 1.08 1.08 1.07 1.08 1.08
Support 1 (S1) 1.02 1.03 0.99 1.02 0.94
Support 2 (S2) 0.95 1.00 0.95 0.93
Support 3 (S3) 0.89 0.95 0.92
Support 4 (S4) 0.89